Oswaldo Cruz Foundation Brazilian Ministry of Health: Insertion of Fiocruz
Total Page:16
File Type:pdf, Size:1020Kb
Oswaldo Cruz Foundation Brazilian Ministry of Health: insertion of Fiocruz Source: MS Role in nation and state building The fight against small pox, bubonic plague, and yellow fever epidemics Campaigns against Malaria: 1905 Itatinga (SP), 1907 Xerém (RJ), 1907 Lassance (MG). Belisário Penna – Lajes – Piauí - 1912 Fiocruz employees packing and stacking boxes containing vials of Yellow fever vaccine in the 1920s Oswaldo Cruz Foundation: Research | Education | Innovation and Production | Surveillance and Reference Services | Health & Medical Care | Environment and Health Promotion | Information and Communication | Quality Control | History of Science and Health | Planning and Management Fiocruz Highlights - 2018 WORKFORCE RESEARCH 11.899 workers 29 research areas PRIMARY CARE AND REFERENCE 5.008 public employees > 1.686 research projects LABORATORIES 6.787 outsourced workers Analysis, consultations 1.683 PhD/DSc degree EDUCATION AND TRAINING OF and examinations HUMAN RESOURCES 82 thousand treated PRODUCTION 37 M.Sc./Ph.D. programs patients 51 Lato Sensu courses 312 thousand laboratory 80 million doses of vaccines reference tests 4,5 million diagnostic reagents 3.461 graduates – postgraduate 291 million drug units 4.171 graduates – Professional 4,8 million bottles of education biopharmaceuticals 1.688.654 registrations UnaSUS (2013 – 2018) Fiocruz International Cooperation Fiocruz International Reference Centers Fiocruz - Who Collaborating Center Other References • Global Health South-South cooperation. • Diagnostic & molecular typing for human • Influenza – pre-candidate . retroviruses • Leptospirosis. • Control of Schistosomiasis • Pharmaceutical Policies. • Typing of Leishmaniasis • Environmental and Public Health. • Measles & other exanthematous viral • Education of Health Technicians. infections • Childhood Blindness. • Polio & other enterovirus infection • Malaria • Epidemiology of Congenital malformations Fiocruz Education and Training • Fiorcuz as the main non-university institution in the training of human resources for the Unified Health System (SUS) • Federal School of Health Governance • Distance Education • Master’s & Doctorate Degrees • Undergraduate courses • Middle Level Technician courses Fiocruz Priority Research Areas Translational programs Infectious diseases Chagas disease(Fio-Chagas) Leishmaniasis (Fio-Leish) Schistosomiasis (Fio-Schisto) Emerging and reemerging diseases (Fio-ER) Tuberculosis and other mycobacteriosis (Fio-Tb) Chronic non-communicable diseases Neurological diseases (Fio-Neuro) Cancer (Fio-Câncer) Metabolic diseases (Fio-Metabol) New Technologies Technologies – Omics and Scientific Computing in Health and Environment (Fio-ROCC) Nanotechnology (Fio-Nano) Synthetic Biology (Fio-BioSin) Health & Medical Care - Reference Centers INFECTIOUS DISEASES • Leishmaniasis, Mycoses, Tuberculosis and other mycobacteria • Sexually Transmitted Diseases and HIV-AIDS • Dengue and other acute Fevers MATERNAL & INFANT CARE • High risk pregnancy, Neonatology, Genetic counseling, • Pediatrics, Lactation and human milk banks • Cervical and uterine cancers HEALTH CENTER - PRIMARY CARE • Health promotion protocols (seniors , AIDS, drug addiction) • Prenatal care • Immunization program • Clinical trials Fiocruz Innovation System – Fiocruz Research Units Technological Infrastructure Prototype Bio-Manguinhos Partners CDTS Plants Farmanguinhos • Universities Bio-Manguinhos CIPBR Partners •CDTS Other STIs Famanguinhos •Partners Partners Health Fiocruz Research and Pre- Clinical Industrial Development Scale-up e Innovation Development Trials Production Networks Production of Vaccines and Medicines by Fiocruz • Supply of vaccines to the National Immunization Program (PNI). • Public producer of biopharmaceuticals in Brazil. • Supplier of diagnostic reagents to the National Program for STD/Aids and for health surveillance actions coordinated by the CGLAB/MS. • Supplier of antiretrovirals for the Unified Health System (SUS). • Support to the Pharmaceutical Care programs of the Ministry of Health. Production and Access to Health Inputs (Bio-Manguinhos) Vaccines Diphtheria, Tetanus, Pertussis and Haemophilus influenzae type b (DTP+Hib):: (5 doses) Yellow Fever: (5 and 10 doses) Haemophilus influenzae b (Hib): conjugated (1 dose) Meningococcal AC: (10 doses) Pneumococcal 10-valente, conjugated (1 dose) Oral Poliomyelitis 1 and 3 attenuated: (25 doses) Inactivated Poliomyelitis: (10 doses) Human rotavirus: (1 dose) Measles, Mumps and Rubella (MMR): (1 and 10 doses) Measles, Mumps, Rubella and Varicella vaccine (MMRV): (1 dose) Production and Access to Health Inputs (Bio-Manguinhos) 15 IVD Tests EIE Canine Leishmaniasis: (384 reactions) IFI Chagas disease: (600 reactions) IFI Human Leishmaniasis: (600 reactions) Helm Test: (100 reactions) Imunoblot rapid DPP® HIV-1/2: (20 reactions) TR DPP® Leishmaniasis: (20 reactions) TR DPP® Leptospirosis: (20 reactions) TR DPP® HIV-1/2: (20 reactions) TR DPP® HIV-1/2 Oral Fluid: (20 reactions) TR DPP® Syohilis: (20 reactions) TR DPP® HIV Syphilis combo: (20 reactions) TR DPP® Syphilis DUO: (20 reactions) TR DPP® Zika IgM/IgG: (20 reactions) Kit Molecular ZDC: (48 reactions) Kit NAT HIV/HCV/HBV: (92 reactions) Production and Access to Health Inputs (Bio-Manguinhos) Biopharmaceuticals Interferon alpha-2b (3, 5 and 10 MUI) Epoetin alpha: (2.000, 4.000 and 10.000 UI) Alphataliglicerase (200 U) Infliximab (100 mg) Interferon beta-1a(22 mcg e 44 mcg) 2018 (in vials): 5.521.504 Production and Access to Health Inputs (FarManguinhos) Drugs (PRODUCTION – Pharmaceutical Units – 2018) • Antimalaric – 227.500 • Direct-acting antivirals- 69.814.190 • Antiviral – 8.120.500 • Immunosuppressive agents - 29.588.350 • Antiparkinsonians – 17.262.480 • Immunossupressive – 2.196.840 • Vitamins and supplements – 6.674.650 2018 (Pharmaceutical Units): 106.890.200 Quality Control in Health • National Institute for Quality Assurance in Health (INCQS) is the country’s main institute dealing with technological issues and standards for assessing the quality of inputs, products, environments and services in the health sector. • It works in collaboration with the National Health Surveillance Agency (Anvisa) and with state and municipal surveillance services in the inspection of industries and laboratories, and in the development of sanitary legislation. Foto: Peter Ilicciev Information and communication • Life Museum (Museu da Vida): guided visits, exhibitions, Science Tent and other cultural attractions. • Canal Saúde (TV channel) • Editora Fiocruz – publisher • Scientific Journals • Portal Fiocruz - website • Fiocruz News Agency Preservation of Scientific, Historical and Cultural Health Heritage Architectural collection: area and buildings listed by the National Institute of Historic and Artistic Heritage. Archival collection: 126 funds and collections of institutional and personal documents of the textual, iconographic, cartographic, sonorous and filmographic genres Museum collection: under the custody of Fiocruz Technical Museum Reserve, it is composed of about 2,000 pieces Microbiological collections • Zoological collections • Botanical collections • Histopathological collections Oswaldo Cruz Foundation: Science and Health for all .